Saudi - Delayed Quote SAR

Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR)

270.00
-0.60
(-0.22%)
At close: May 14 at 3:19:53 PM GMT+3
Currency in SAR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
11,836,804.68
11,200,434.26
9,508,438.77
8,310,738.51
7,250,472.19
Cost of Revenue
7,941,565.83
7,456,175.87
6,238,390.70
5,562,603.30
4,920,242.73
Gross Profit
3,895,238.85
3,744,258.40
3,270,048.07
2,748,135.22
2,330,229.46
Operating Expense
1,452,353.48
1,371,226.32
1,160,608.65
1,036,109.86
853,381.61
Operating Income
2,442,885.37
2,373,032.08
2,109,439.42
1,712,025.36
1,476,847.85
Net Non Operating Interest Income Expense
-185,652.58
-122,776.61
-1,766.47
-20,176.26
-38,689.45
Pretax Income
2,414,936.49
2,412,858.45
2,169,986.91
1,796,657.10
1,501,343.68
Tax Provision
37,314.64
42,897.37
68,516.33
107,707.93
114,066.32
Net Income Common Stockholders
2,321,351.24
2,315,290.80
2,046,013.92
1,650,750.05
1,376,615.20
Diluted NI Available to Com Stockholders
2,321,351.24
2,315,290.80
2,046,013.92
1,650,750.05
1,376,615.20
Basic EPS
6.64
--
5.85
4.72
3.93
Diluted EPS
6.64
--
5.85
4.72
3.93
Basic Average Shares
350,000
--
350,000
350,000
350,000
Diluted Average Shares
350,000
--
350,000
350,000
350,000
Total Operating Income as Reported
2,426,114.55
2,356,261.26
2,095,648.92
1,700,487.33
1,466,151.27
Rent Expense Supplemental
--
24,989.94
16,703.77
10,126.44
7,812.20
Total Expenses
9,393,919.31
8,827,402.19
7,398,999.35
6,598,713.16
5,773,624.34
Net Income from Continuing & Discontinued Operation
2,321,351.24
2,315,290.80
2,046,013.92
1,650,750.05
1,376,615.20
Normalized Income
2,278,348.32
2,272,389.53
2,046,013.92
1,650,750.05
1,376,615.20
Interest Income
--
56,757.20
82,130.66
40,718.51
9,903.14
Interest Expense
225,638.95
162,762.99
70,106.62
49,356.75
37,896.01
Net Interest Income
-185,652.58
-122,776.61
-1,766.47
-20,176.26
-38,689.45
EBIT
2,640,575.44
2,575,621.43
2,240,093.53
1,846,013.85
1,539,239.69
EBITDA
3,131,064.20
2,996,422.79
2,552,772.03
2,155,236.66
1,854,033.20
Reconciled Cost of Revenue
7,941,565.83
7,456,175.87
6,238,390.70
5,562,603.30
4,920,242.73
Reconciled Depreciation
490,488.76
420,801.36
312,678.50
309,222.81
314,793.51
Net Income from Continuing Operation Net Minority Interest
2,321,351.24
2,315,290.80
2,046,013.92
1,650,750.05
1,376,615.20
Total Unusual Items Excluding Goodwill
43,677.81
43,677.81
0
--
--
Total Unusual Items
43,677.81
43,677.81
0
--
--
Normalized EBITDA
3,087,386.39
2,952,744.99
2,552,772.03
2,155,236.66
1,854,033.20
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
674.89
776.53
0
0
0
12/31/2021 - 3/17/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

4017.SR Dr. Soliman Abdel Kader Fakeeh
46.35
-0.75%
 
4002.SR Mouwasat Medical Services Company
77.60
-0.77%
 
4004.SR Dallah Healthcare Company
118.60
-1.66%
 
4007.SR Al Hammadi Holding Company
39.90
-0.25%
 
4009.SR Middle East Healthcare Company
64.00
-1.54%
 
4005.SR National Medical Care Company
162.40
-0.85%
 
4018.SR Almoosa Health Company
164.00
-0.97%
 
9544.SR Future Care Trading Co.
3.8100
-4.75%
 
CHE Chemed Corporation
553.52
-0.66%
 
AGL agilon health, inc.
2.6700
-1.11%